Stay updated with breaking news from Pharmaxis Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Clinical-stage drug development company Pharmaxis Ltd (ASX:PXS, OTC:PMXSF) has taken a leap forward in the fight against pancreatic ductal adenocarcinoma...
The ASX has logged a stellar day, with the benchmark S&P/ASX 200 finishing up 1.19%, or 86 points, to 7,297 after news that July inflation had cooled more...
ASX futures are pointing to a modest 0.35% or 25-point lift in trading today, having climbed 0.63% or 44.6 points yesterday. In the US, the Dallas Fed...
Pharmaxis (OTCMKTS:PXSLY – Get Free Report) and Theravance Biopharma (NASDAQ:TBPH – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, analyst recommendations, risk, earnings and profitability. Earnings & Valuation This table compares Pharmaxis and […]
The oncology sector – like most of the healthcare sector – has been struggling post-COVID boom, faltering in the face of a tight financial market reluctant...